ArticleFrontiers in medicine2022

A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes.

Azam Doustmohammadian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.